Beth Fand Incollingo

Articles

Dosing for Obesity New Chemotherapy Guidelines Linked to Body Weight

October 26th 2012

For those who treat overweight or obese cancer patients, choosing doses of chemotherapy can be a sweat-producing endeavor.

Researchers Remain in Pursuit of Angiogenesis Inhibition

October 19th 2012

Many researchers and oncologists anticipate a role for antiangiogenic strategies in future treatment paradigms; yet just what that role will be remains elusive.

Drug Shortages Frustrate Nurses and Jeopardize Patient Care

October 15th 2012

The promise of a solution somewhere on the horizon for America's drug shortages isn't enough for the registered nurse who navigates shortages every day.

Noted Researcher Offers Overview of Emerging Therapies

October 15th 2012

Within the past two years, the oncology community has seen the FDA approve three practice-changing therapies for breast cancer and the progress of a promising fourth agent, T-DM1.

Breast Oncologists Incorporate New Treatments, Grapple With Ongoing Challenges

October 5th 2012

During the 11th International Congress on The Future of Breast Cancer, Hope Rugo, MD, offered a snapshot of the research community's progress in the study and treatment of the disease.

Anemia Linked to Functional Disability in Older Patients With Cancer

September 4th 2012

Anemia is common and associated with functional disability in patients with cancer aged ≥65 years, according to the results of a study presented at ASCO 2012.

Lower-Income Patients Less Likely to Participate in Clinical Trials

September 4th 2012

Patients with cancer who have lower incomes are less likely to participate in clinical trials, according to a large national survey.

Drug Shortage Dilemma: Trying New Tactics in a Tough Arena

August 29th 2012

Fresh strategies for grappling with the chronic, and at times critical, shortages of cancer drugs that have frustrated the oncology community for the past decade are likely to help alleviate supply problems.

Non-Guideline Treatments for Febrile Neutropenia Are Commonly Used, but Ineffective

August 28th 2012

Two medications that are not recommended in guidelines for the standard treatment of cancer-related febrile neutropenia are commonly used- particularly outside of high-volume medical settings- yet are not effective.

Newly Published Results Show Survival Benefit with Enzalutamide in Prostate Cancer

August 16th 2012

The novel drug enzalutamide (formerly MDV3100) significantly improved overall survival in men with metastatic castrate-resistant prostate cancer (mCRPC).

Older Women With Early Cervical Cancer Are Less Likely to Have Surgery

August 6th 2012

Among patients with early-stage cervical cancer, women aged greater than 65 years are less likely than younger women to be treated with surgery as compared with chemoradiation.

Study Supporting Lower Threshold on PSA Risk Levels Wins Award

August 6th 2012

Men with a baseline PSA between 1.5 and 4.0 ng/mL faced a 15-fold increase in prostate cancer over a four-year period as compared with men whose baseline PSA levels were

Leading Enzalutamide Investigator Offers Insights Into Pivotal Data

August 1st 2012

Since the phase III AFFIRM trial of enzalutamide was halted after meeting its endpoint of improved OS, physicians have remained hopeful about its potential as a treatment for prostate cancer.

Oncology Leaders Praise Health Law Ruling-With Caveats

June 28th 2012

Leaders in the oncology care and research communities largely applauded the US Supreme Court ruling Thursday that upholds the Affordable Care Act.

Affirming the Promise of Enzalutamide: A New Opportunity for Integrative Care in Prostate Cancer

June 25th 2012

Enzalutamide seems poised to become an exciting addition to the growing list of novel therapies approved for the treatment of prostate cancer.

Defining Quality of Life: Psychologist's Questionnaires Play Growing Role in Cancer Research

June 15th 2012

An interview with David Cella, PhD, the developer of the FACIT system of questionnaires that scientifically measure the quality of life of patients being treated for cancer.

From a Distance: Managing Side Effects in Outpatients

June 12th 2012

Checking in with patients can bring positive results, since oncology nurses are able to offer interventions for most symptoms of cancer treatment. Includes an in-depth look at telephone triage.

IPCC Case-Based Discussion: How Should We Sequence Therapy?

June 12th 2012

Three case studies focused on how best to sequence therapy in prostate cancer were presented by Daniel P. Petrylak, MD, and discussed by a panel that included Robert Dreicer, MD, and Oliver Sartor, MD.

Pilot Study Evaluates a Proposed Quality Measure for Family History Collection and Genetic Testing Referral

June 5th 2012

Only half of those with breast cancer and one-quarter of those with colon cancer were referred for genetic counseling or testing by their physicians.

FDA and Industry Collaborating to Prevent Cancer Drug Shortages

June 5th 2012

Drug manufacturers are working with the FDA to report anticipated shortages earlier and ensure alternative sources of needed drugs are available.

NEXT PAGE
PREVIOUS PAGE